Lager W, von Lucadou I, Nischik H, Nowak T, Preidel W, Ruprecht L, Stanzel M J, Tegeder V
Corporate Research and Development, Siemens AG, Erlangen.
Horm Metab Res. 1994 Nov;26(11):526-30. doi: 10.1055/s-2007-1001749.
An electrocatalytic glucose sensor for in vivo application has been developed to determine the glucose level in blood and further to control the insulin dosage in a closed loop system for diabetes therapy. The principle of the electrocatalytic glucose sensor is based on the direct electrochemical oxidation of glucose at a membrane-covered platinum electrode. For a possible clinical application the sensor was built as a catheter. A set of implantations in the vena cava of sheep demonstrated the potential feasibility of the sensor. The sensor values were simultaneously checked by the enzymatic analysis of glucose in blood samples drawn separately from a femoral vein. It was possible to determine the glucose concentration in sheep for more than 130 days with tolerable deviations from glucose reference measurements. The mean error was 2.5 mmol/l. One of the catheters was explanted after 211 days and the histological examination revealed a good biocompatibility of all materials used. In additional experiments, the differences of the glucose concentration in vena cava as well as in the anterior and posterior femoral veins of a sheep were examined during glucose tolerance tests. These experiments verified our method of in vivo calibration of the long-term implantable glucose sensor.
一种用于体内应用的电催化葡萄糖传感器已被开发出来,用于测定血液中的葡萄糖水平,并进一步在糖尿病治疗的闭环系统中控制胰岛素剂量。该电催化葡萄糖传感器的原理基于葡萄糖在膜覆盖的铂电极上的直接电化学氧化。为了实现可能的临床应用,该传感器被制成导管形式。在绵羊腔静脉中的一系列植入实验证明了该传感器的潜在可行性。通过对从股静脉单独抽取的血样进行葡萄糖酶分析,同时对传感器值进行了检查。在超过130天的时间里,可以测定绵羊体内的葡萄糖浓度,与葡萄糖参考测量值的偏差在可容忍范围内。平均误差为2.5 mmol/l。其中一根导管在211天后被取出,组织学检查显示所用的所有材料都具有良好的生物相容性。在额外的实验中,在葡萄糖耐量试验期间,检查了绵羊腔静脉以及股静脉前后段的葡萄糖浓度差异。这些实验验证了我们对长期可植入葡萄糖传感器进行体内校准的方法。